Amarillo, TX 的 心臟衰竭 臨床試驗
8 項針對 心臟衰竭 的研究正在 Amarillo（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
招募中3 期
- Research Site, Amarillo
- Research Site, Amarillo
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
招募中3 期
- Pharmatex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
招募中3 期
- Pharmatex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
招募中2 期
- Amarillo Medical Specialists, Amarillo
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- PharmaTex Research, LLC, Amarillo
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
招募中3 期
- CON-10045 Amarillo, TX Investigational Site, Amarillo
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
招募中3 期
- Amarillo, TX Investigative Site 10045, Amarillo
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- PharmaTex Research, LLC, Amarillo
其他城市的 心臟衰竭 試驗
- New York City, NY51 項研究
- Boston, MA44 項研究
- Dallas, TX42 項研究
- Houston, TX36 項研究
- Cleveland, OH33 項研究
- Chicago, IL31 項研究
- Philadelphia, PA31 項研究
- San Francisco, CA29 項研究
- St. Louis, MO26 項研究
- Durham, NC26 項研究
- Kansas City, MO25 項研究
- Atlanta, GA25 項研究
Amarillo 的其他研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。